» Articles » PMID: 27974323

Do Celebrity Endorsements Matter? Observational Study of BRCA Gene Testing and Mastectomy Rates After Angelina Jolie's New York Times Editorial

Overview
Journal BMJ
Specialty General Medicine
Date 2016 Dec 16
PMID 27974323
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Objective:  To examine the effect on BRCA testing and mastectomy rates of a widely viewed 2013 New York Times editorial by public figure Angelina Jolie that endorsed BRCA testing and announced Jolie's decision to undergo preventive mastectomy.

Design:  Observational study with difference-in-difference analysis.

Setting:  Commercially insured US population.

Participants:  Women aged 18-64 years with claims in the Truven MarketScan commercial claims database (n=9 532 836).

Main Outcome Measures:  Changes in BRCA testing rates in the 15 business days before versus after 14 May 2013 (editorial date) compared with the change in the same period in 2012; mastectomy rates in the months before and after publication, both overall and within 60 days of BRCA testing among women who were tested; national estimates of incremental tests and expenditures associated with Jolie's article in the 15 days after publication.

Results:  Daily BRCA test rates increased immediately after the 2013 editorial, from 0.71 tests/100 000 women in the 15 business days before to 1.13 tests/100 000 women in the 15 business days after publication. In comparison, daily test rates were similar in the same period in 2012 (0.58/100 000 women in the 15 business days before 14 May versus 0.55/100 000 women in the 15 business days after), implying a difference-in-difference absolute daily increase of 0.45 tests/100 000 women or a 64% relative increase (P<0.001). The editorial was associated with an estimated increase of 4500 BRCA tests and $13.5m (£10.8m; €12.8) expenditure nationally among commercially insured adult women in those 15 days. Increased BRCA testing rates were sustained throughout 2013. Overall mastectomy rates remained unchanged in the months after publication, but 60 day mastectomy rates among women who had a BRCA test fell from 10% in the months before publication to 7% in the months after publication, suggesting that women who underwent tests as a result of to the editorial had a lower pre-test probability of having the BRCA mutation than women tested before the editorial.

Conclusions:  Celebrity endorsements can have a large and immediate effect on use of health services. Such announcements can be a low cost means of reaching a broad audience quickly, but they may not effectively target the subpopulations that are most at risk for the relevant underlying condition.

Citing Articles

Implants versus autologous tissue flaps for breast reconstruction following mastectomy.

Rocco N, Catanuto G, Accardo G, Velotti N, Chiodini P, Cinquini M Cochrane Database Syst Rev. 2024; 10:CD013821.

PMID: 39479986 PMC: 11526434. DOI: 10.1002/14651858.CD013821.pub2.


Genetic Testing Among Breast Cancer Patients in the Eastern Region of Saudi Arabia: Single-Center Experience.

Ghareeb G, Nass Z, Abu-Grain S, Alnaji A, Almohanna H, Nasser H J Epidemiol Glob Health. 2024; 14(3):1351-1357.

PMID: 39256315 PMC: 11442735. DOI: 10.1007/s44197-024-00296-4.


Online Search Interest in Gynecologists After the Release of the Film Barbie.

Senechal E, Bray C, Worsham C, Jena A JAMA Netw Open. 2024; 7(7):e2424658.

PMID: 39052295 PMC: 11273229. DOI: 10.1001/jamanetworkopen.2024.24658.


Clinical Strategies in Gene Screening Counseling for the Healthy General Population.

Kang H, Choe E Korean J Fam Med. 2024; 45(2):61-68.

PMID: 38528647 PMC: 10973703. DOI: 10.4082/kjfm.23.0254.


Personalized medicine with germline pathogenic variants: Importance of population- and region-wide evidence.

Usui Y, Momozawa Y Cancer Sci. 2023; 114(10):3816-3824.

PMID: 37530079 PMC: 10551596. DOI: 10.1111/cas.15922.


References
1.
Moyer V . Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013; 160(4):271-81. DOI: 10.7326/M13-2747. View

2.
Evans D, Wisely J, Clancy T, Lalloo F, Wilson M, Johnson R . Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women. Breast Cancer Res. 2015; 17:143. PMC: 4659163. DOI: 10.1186/s13058-015-0650-8. View

3.
Kehl K, Shen C, Litton J, Arun B, Giordano S . Rates of BRCA1/2 mutation testing among young survivors of breast cancer. Breast Cancer Res Treat. 2015; 155(1):165-73. PMC: 5521172. DOI: 10.1007/s10549-015-3658-y. View

4.
Evans D, Barwell J, Eccles D, Collins A, Izatt L, Jacobs C . The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res. 2014; 16(5):442. PMC: 4303122. DOI: 10.1186/s13058-014-0442-6. View

5.
Juthe R, Zaharchuk A, Wang C . Celebrity disclosures and information seeking: the case of Angelina Jolie. Genet Med. 2014; 17(7):545-53. PMC: 4408206. DOI: 10.1038/gim.2014.141. View